Tenet Healthcare Corporation $THC Shares Sold by LSV Asset Management

LSV Asset Management reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 18.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 187,800 shares of the company’s stock after selling 41,100 shares during the quarter. LSV Asset Management’s holdings in Tenet Healthcare were worth $37,320,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Triumph Capital Management acquired a new position in shares of Tenet Healthcare in the 3rd quarter worth approximately $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare in the 4th quarter valued at approximately $29,000. Westside Investment Management Inc. boosted its position in Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after buying an additional 96 shares during the period. Finally, Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare in the 2nd quarter valued at approximately $35,000. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares in the company, valued at $6,983,853.13. This trade represents a 18.16% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider R. Scott Ramsey sold 8,017 shares of Tenet Healthcare stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 46,517 shares of company stock valued at $10,943,111. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $174.00 on Monday. The stock has a market cap of $14.99 billion, a P/E ratio of 9.05, a price-to-earnings-growth ratio of 1.14 and a beta of 1.30. The company has a fifty day simple moving average of $194.07 and a 200-day simple moving average of $202.90. Tenet Healthcare Corporation has a 12-month low of $146.60 and a 12-month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the company earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 17.67 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

THC has been the subject of several analyst reports. Robert W. Baird lowered their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, May 5th. Wall Street Zen cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Barclays lowered their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a research note on Friday, May 1st. Finally, TD Cowen reissued a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.